Demo Data from VLDB 2026 / reviewers in the wild / expert
Xiaoping Su
dblp:82/6458
· DBLP profile ↗
2ranked-venue papers
1as first author
0since 2021 · last 2013
0000-0003-1824-943XORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
cancer genomics |
0.3 | 2 | 2013 | VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue · Bioinform. 2013 PurityEst: estimating purity of human tumor samples using next-generation sequencing data · Bioinform. 2012 |
Bioinformatics and computational biology › genomics › viral genomics
viral integration detection |
0.2 | 1 | 2013 | VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue · Bioinform. 2013 |
Bioinformatics and computational biology › cancer genomics
tumor purity estimation |
0.1 | 1 | 2012 | PurityEst: estimating purity of human tumor samples using next-generation sequencing data · Bioinform. 2012 |
Methods — techniques the papers use, named apart from their topics
next-generation sequencing analysis · 0.2somatic mutation analysis · 0.1allelic differential representation · 0.1
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2013 | VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissueabstractSUMMARY: We developed a new algorithmic method, VirusSeq, for detecting known viruses and their integration sites in the human genome using next-generation sequencing data. We evaluated VirusSeq on whole-transcriptome sequencing (RNA-Seq) data of 256 human cancer samples from The Cancer Genome Atlas. Using these data, we showed that VirusSeq accurately detects the known viruses and their integration sites with high sensitivity and specificity. VirusSeq can also perform this function using whole-genome sequencing data of human tissue. AVAILABILITY: VirusSeq has been implemented in PERL and is available at http://odin.mdacc.tmc.edu/∼xsu1/VirusSeq.html. CONTACT: [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Yunxin Chen, Erika J. Thompson, Nizar M. Tannir, John N. Weinstein, Xiaoping Su |
Bioinform. | 6 |
| 2012 | PurityEst: estimating purity of human tumor samples using next-generation sequencing dataabstractUNLABELLED: We developed a novel algorithm, PurityEst, to infer the tumor purity level from the allelic differential representation of heterozygous loci with somatic mutations in a human tumor sample with a matched normal tissue using next-generation sequencing data. We applied our tool to a whole cancer genome sequencing datasets and demonstrated the accuracy of PurityEst compared with DNA copy number-based estimation. AVAILABILITY: PurityEst has been implemented in PERL and is available at http://odin.mdacc.tmc.edu/~xsu1/PurityEst.html. Xiaoping Su, Funda Meric-Bernstam, John N. Weinstein |
Bioinform. | 1 |